Dr. Thomas Alan Hanscom, MD

Dr. Hanscom practices at The Retina Partners in Encino, California.

Dr. Hanscom's NPI, 1063476448, was assigned on April 13, 2006. Dr. Hanscom graduated from University of Illinois College of Medicine - Chicago in 1973. Dr. Hanscom holds California license G34319.

Dr. Hanscom's primary practice is The Retina Partners, at 16500 W Ventura Blvd, Encino, CA 91436 in Los Angeles County. The practice phone is (818) 788-9333.

Dr. Hanscom's primary practice is The Retina Partners in Encino, California. Dmand AI also links Dr. Hanscom to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanscom practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Hanscom's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Hanscom is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Hanscom's licenses on file in 2 states: California and North Carolina.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, eyelid inflammation, inflammation of iris, laser destruction of retinal or choroid lesions, retinal detachment and retinal occlusion among the conditions Dr. Hanscom treats.

CMS data shows 28,134 Medicare services from Dr. Hanscom across 15 procedure codes in 2024, for 823 Medicare patients. Medicare paid $2,316,803 for them. Every service was in an office.

CMS counts 823 Medicare patients who saw Dr. Hanscom in 2024. The largest group is 75 to 84, with 312 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hanscom's median patient age at 73, with 57% women.

In 2024, Dr. Hanscom wrote 126 Medicare Part D claims for 67 patients. 40% of them were for generic drugs. CMS names the drug for 68 of them, across 3 drugs with 11 or more claims each, at $2,408 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Hanscom for performance year 2024, reported as part of a group. Dr. Hanscom accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Hanscom. The most frequent topics are Fluorescein Angiography, Visual Acuity and Embolectomy. Dr. Hanscom has published most often in Am J Ophthalmol. Dr. Hanscom's most frequent co-authors are Kenneth Robert Diddie, MD, Michael Reynard, MD and Antonio Capone, MD.

CMS Open Payments shows 148 general payments to Dr. Hanscom from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $3,283. It also lists 1 research payment totaling $2,500 in 2016.

Dmand AI lists 4 awards for Dr. Hanscom, most recently Top Doctors:LA Area in 2013.

Dr. Hanscom graduated from University of Illinois College of Medicine - Chicago in 1973. Dr. Hanscom is a member of AAO.

Dr. Hanscom is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.